NCT02479646View on ClinicalTrials.gov

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

PHASE1CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

MYL-1401H

BIOLOGICAL

EU-Neulasta

BIOLOGICAL

US-Neulasta

Trial Locations (1)

9471

PRA Health Sciences - Early Development Services, Zuidlaren

Sponsors

Lead Sponsor

Mylan Inc.
All Listed Sponsors
collaborator

Mylan GmbH

INDUSTRY

lead

Mylan Inc.

INDUSTRY